>

Seminar Series

students in a lecture hall listening to a person speak

The VICB seminar series is a course in the Chemical and Physical Biology (CPB) Program - CPBP 8310 (Graduate Seminar in Chemical Biology). All seminars take place on Wednesdays at 12:15 PM in 1220 MRB III.

Fall 2026

  • headshot of Binghe Wang

    September 9

    12:15PM 1220 MRBIII

    Binghe Wang, Georgia State

    Studying the Puzzle of Reactive Oxygen Species: One Piece at a Time

  • wei lu headshot

    September 16

    12:15PM 1220 MRBIII

    Wei Lü, Northwestern University

    cosponsored by the Vanderbilt Brain Institute

  • Tingwei Mu headshot

    September 23

    12:15PM 1220 MRBIII

    Tingwei Mu, Case Western Reserve University

    Adapting proteostasis to correct GABAA receptor misfolding diseases

    *cosponsored by the Center for Structural Biology

  • Ulrich Hartl headshot

    October 1

    4:00PM 202 LH

    F. Ulrich Hartl, Max-Planck-Institute of Biochemistry

    organized by BCHM; cosponsored by VICB

  • Manajit-Hayer-Hartl headshot

    October 2

    12:00PM 214 LH

    Manajit Hayer-Hartl, Max-Planck-Institute of Biochemistry

    organized by BCHM; cosponsored by VICB

  • Danica Fujumori headshot

    October 14

    12:15PM 1220 MRBIII

    Danica Fujimori, University of California - San Francisco

  • Ming Hammond headshot

    October 28

    12:15PM 1220 MRBIII

    Ming Hammond, University of Utah

    Studying bacterial signaling and antibiotic activity in real-time in live cells

  • bill tansey headshot

    November 4

    12:15PM 1220 MRBIII

    Bill Tansey, Vanderbilt University

  • Eranthie Weerapana headshot

    November 11

    12:15PM 1220 MRBIII

    Eranthie Weerapana, Boston College

    cosponsored by the Department of Chemistry

  • Nicholas Wu headshot

    November 18

    12:15PM 1220 MRBIII

    Nicholas Wu, University of Illinois - Urbana Champaign

  • Jie Sun headshot

    December 2

    12:15PM 1220 MRBIII

    Jie Sun, University of Tennessee - Knoxville

Past Seminar Speakers

  • Summer 2026
    • Clifton Barry III, National Institute of Allergy and Infectious Diseases; Development of MK-7762: a safe oxazolidinone for the treatment of all forms of tuberculosis
  • Spring 2026
    • Caroline Proulx, North Carolina State University; New Strategies for Peptide Mimicry and Late-Stage Functionalizations
    • Michael Villalobos, Vanderbilt University; CTTC – Accelerating Vanderbilt’s Innovation Ecosystem
    • Amber Teufel, co-hosted with Sydney McKee, Procter and Gamble; Behind the Brands: How Chemical Biologists Shape P&G’s Future
    • Daniel Herschlag, Stanford University; From Structure-Function to Ensemble-Function: A New Paradigm for Quantitative Understanding of Protein Function
    • Joseph Jez, Washington University in St. Louis; Two Stories from Plant Natural Product Biosynthesis: One Sweet and One Bitter
    • Robert Coffey, Vanderbilt University Medical Center; Doubling Down On DPEP1
    • Richard E. Lee, St. Jude Children's Research Hospital; Fighting Intrinsic Resistance in Mycobacteria
    • Kevin Gardner, The City College of New York; Harnessing Nature’s Switches for Our Medicines and Tools: Structural Studies of Environmental Sensor Proteins
    • Emily Leproust, Twist Bioscience; Write, Read, Heal: The Convergence of NGS and Synthetic Biology in Next-Gen Therapeutics Research
  • Fall 2025

     

    • Chaitan Khosla, Stanford University; Chemical Biology of Celiac Disease
    • Christian Melander, University of Notre Dame; Small Molecule Approaches to Disarming Antibiotic Resistance Mechanisms
    • Mohammad Seyedsayamdost, Princeton University; Natural Product Antibiotics: Past, Present, Future, Co-sponsored by the Department of Chemistry
    • Tobin Sosnick, The University of Chicago; The Relationship Between Protein Function and Structurally Resolved Energetics Measured Using Hydrogen Exchange
    • Yan Zhang, Zhejiang University, China; GPCR Exoframe Modulators: From de novo design to applications, Co-sponsored by the Department of Pharmacology
    • Danette Daniels, Foghorn Therapeutics, Inc.; Towards new cancer medicines with degraders of chromatin regulatory proteins
    • Mei Hong, Massachusetts Institute of Technology; Deconstructing and Reconstructing Tau by Solid-State NMR
    • Ben Brown, Vanderbilt University; A Generalizable Deep Learning Framework for Structure-Based Protein-Ligand Affinity Ranking
    • Alex Waterson, Vanderbilt University; Expanding the E3 ligase toolkit using fragment-based methods